Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces its tentative financial calendar for 2016, which is set as follows:
February 18, 2016: Publication of 2015 financial statements, with management comments.
The 2015 Reference Document and Financial Report (included in the Reference Document) will be released during the second quarter of 2016
May 4, 2016: Publication of revenue for 1Q2016, with management comments.
June 2, 2016: Annual shareholders meeting in Marseille.
September 8, 2016: Publication of financial statements as of June 30, 2016, with management comments.
November 3, 2016: Publication of revenue for 3Q2016, with management comments.
All corporate information on the Company, such as its financial statements or its corporate presentations, is available on the Company’s website in the Investors’ section.
| PR in English | 67.89 KB |
| CP en français | 67.93 KB |